ZNF483
Zinc finger protein 483
Also known as: KIAA1962, ZKSCAN16, ZN483_HUMAN, ZSCAN48
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TF39
- Gene
- ZNF483
- Ensembl
- ENSG00000173258
- Chromosome
- 9
- Canonical length
- 744 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoli
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
744 residues, UniProt reviewed canonical sequence.
>Q8TF39|ZNF483
1 MQAVVPLNKM TAISPEPQTL ASTEQNEVPR VVTSGEQEAI LRGNAADAES FRQRFRWFCY
61 SEVAGPRKAL SQLWELCNQW LRPDIHTKEQ ILELLVFEQF LTILPGEIRI WVKSQHPESS
121 EEVVTLIEDL TQMLEEKDPV SQDSTVSQEE NSKEDKMVTV CPNTESCESI TLKDVAVNFS
181 RGEWKKLEPF QKELYKEVLL ENLRNLEFLD FPVSKLELIS QLKWVELPWL LEEVSKSSRL
241 DESALDKIIE RCLRDDDHGL MEESQQYCGS SEEDHGNQGN SKGRVAQNKT LGSGSRGKKF
301 DPDKSPFGHN FKETSDLIKH LRVYLRKKSR RYNESKKPFS FHSDLVLNRK EKTAGEKSRK
361 SNDGGKVLSH SSALTEHQKR QKIHLGDRSQ KCSKCGIIFI RRSTLSRRKT PMCEKCRKDS
421 CQEAALNKDE GNESGEKTHK CSKCGKAFGY SASLTKHRRI HTGEKPYMCN ECGKAFSDSS
481 SLTPHHRTHS GEKPFKCDDC GKGFTLSAHL IKHQRIHTGE KPYKCKDCGR PFSDSSSLIQ
541 HQRIHTGEKP YTCSNCGKSF SHSSSLSKHQ RIHTGEKPYK CGECGKAFRQ NSCLTRHQRI
601 HTGEKPYLCN DCGMTFSHFT SVIYHQRLHS GEKPYKCNQC EKAFPTHSLL SRHQRIHTGV
661 KPYKCKECGK SFSQSSSLNE HHRIHTGEKP YECNYCGATF SRSSILVEHL KIHTGRREYE
721 CNECEKTFKS NSGLIRHRGF HSAELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF483 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 20 nTPM
- pituitary gland: 14 nTPM
- hypothalamus: 12 nTPM
- cerebral cortex: 11 nTPM
- retina: 11 nTPM
- basal ganglia: 10 nTPM
Single-cell type
- pituicytes/fscs: 340 nCPM
- lactotrophs: 313 nCPM
- somatotrophs: 287 nCPM
- thyrotrophs: 277 nCPM
- other brain neurons: 227 nCPM
- corticotrophs: 222 nCPM
Immune cell
- naive CD8 T-cell: 3.5 nTPM
- naive CD4 T-cell: 3.2 nTPM
- basophil: 2.9 nTPM
- gdT-cell: 2.7 nTPM
- memory CD4 T-cell: 1.7 nTPM
- MAIT T-cell: 1.5 nTPM
Brain region
- cerebellum: 184 nTPM
- hypothalamus: 181 nTPM
- basal ganglia: 144 nTPM
- cerebral cortex: 139 nTPM
- midbrain: 132 nTPM
- white matter: 125 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZNF483.
Disease | ImmuneIEDB
Conditions an epitope on ZNF483 was assayed in.
- viral infectious disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.4
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF483 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF483 as an antibody target. Whether an autoantibody or antibody against ZNF483 could matter depends on whether native ZNF483 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF483 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF483 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...